Expert Review of Anti-Infective Therapy [ISSN 1478-7210]; [e-ISSN 1744-8336] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on therapeutics and diagnostics in the treatment of infectious disease.

Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

Articles focus on the following key areas:

    Antibiotics
    Drug resistance and drug therapy
    Infectious disease medicine
    Antibacterial, antimicrobial, antifungal and antiviral approaches
    Diagnostic tests

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Anti-infective Therapy, part of the Expert Collection brand.

Laurent Belec, Hôpital européen Georges Pompidou, France 

Richard Burchmore, University of Glasgow, UK 

Virander S. Chauhan, International Center for Genetic Engineering and Biotechnology, India 

Stuart Cohen, UC Davis Medical Center, CA, USA 

Clyde S. Crumpacker, Beth Israel Deaconess Medical Center, MA, USA 

Susanna Esposito, Pediatric Clinic, Pietro Barilla Children’s Hospital, University of Parma, Parma, Italy 

Matthew Falagas, Henry Dunant Hospital Center and Alfa Institute of Biomedical Sciences, Athens, Greece 

Dean H. Hamer, National Cancer Institute, National Institutes of Health, MD, USA 

Hans H. Hirsch, University of Basel, Switzerland 

Po-Ren Hsueh, National Taiwan University Hospital, Taiwan 

Stefan Kunz, University Hospital Center and University of Lausanne, Switzerland 

David C. Montefiori, Duke University Medical Center, NC, USA 

David Nicolau, Center for Anti-Infective Research & Development, Hartford Hospital, Connecticut, USA 

John R. Perfect, Duke University Medical Center, NC, USA 

Mario Poljak, University of Ljubljana, Slovenia 

Rajendra Prasad, Amity University Haryana, Gurgaon, India 

Thomas C. Quinn, Johns Hopkins Center for Global Health, MD, USA 

Luis M. Schang, University of Alberta, Canada 

William M. Scheld, University of Virginia Health System, VA, USA 

Monica A. Slavin, University of Melbourne, Australia 

Jack D. Sobel, Wayne State University School of Medicine, MI, USA 

Glenn. S. Tillotson, GST Micro LLC, PA & PHRI Newark NJ, USA 

Robert G. Will, National Creutzfeldt-Jakob Disease Surveillance Unit, UK 

Jonathan W. Yewdell, National Institute of Allergy & Infectious Diseases, MA, USA 

Michael A. Zasloff, Georgetown University School of Medicine, DC, USA 

George G. Zhanel, University of Manitoba, MB, Canada